- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 305/06 - Hydrogénosulfates
Détention brevets de la classe C07C 305/06
Brevets de cette classe: 50
Historique des publications depuis 10 ans
|
3
|
4
|
5
|
1
|
3
|
3
|
4
|
5
|
5
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Handa Oncology, LLC | 24 |
6 |
| BASF SE | 21308 |
4 |
| Translate bio, Inc. | 415 |
3 |
| Mainstream Pine Products, LLC | 59 |
3 |
| The Procter & Gamble Company | 21849 |
2 |
| Allergan, Inc. | 2162 |
2 |
| Lawrence Livermore National Security, LLC | 1976 |
2 |
| Arkema France | 4242 |
2 |
| Harcros Chemicals Inc. | 33 |
2 |
| Ultimate EOR Services, LLC | 11 |
2 |
| Specialty Operations France | 923 |
2 |
| F. Hoffmann-La Roche AG | 7819 |
1 |
| Hoffmann-La Roche Inc. | 3796 |
1 |
| Halliburton Energy Services, Inc. | 21320 |
1 |
| Merck Patent GmbH | 5729 |
1 |
| ExxonMobil Chemical Patents Inc. | 3776 |
1 |
| Rohm and Haas Company | 2947 |
1 |
| Dow Global Technologies LLC | 10960 |
1 |
| Board of Regents, The University of Texas System | 6117 |
1 |
| Korea Institute of Science and Technology | 2248 |
1 |
| Autres propriétaires | 11 |